Skip to main content

Published locations for Phase-3 study: Leukemia patients live longer with ibrutinib

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Phase-3 study: Leukemia patients live longer with ibrutinib

User login

  • Reset your password
  • /content/phase-3-study-leukemia-patients-live-longer-ibrutinib
  • /hematologynews/article/254888/cll/phase-3-study-leukemia-patients-live-longer-ibrutinib
  • /hematology-oncology/article/254888/cll/phase-3-study-leukemia-patients-live-longer-ibrutinib
  • /b-cell-lymphoma-icymi/article/254888/cll/phase-3-study-leukemia-patients-live-longer-ibrutinib